Literature DB >> 13585293

A comparison of intravenous calcium disodium versenate and oral penicillamine in promoting elimination of lead.

C E HARRIS.   

Abstract

Entities:  

Keywords:  CYSTEINE/related compounds; EDATHAMIL/therapeutic use; LEAD POISONING/therapy

Mesh：

Substances：

Year:  1958        PMID： 13585293      PMCID： PMC1830227     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Disturbances of aminoacid metabolism following liver injury; a study by means of paper chromatography.

Authors:  J M WALSHE
Journal:  Q J Med       Date:  1953-10

2.  Oral administration of edathamil calcium disodium (calcium disodium versenate).

Authors:  L D PAGNOTTO; H B ELKINS; I BAYKA
Journal:  AMA Arch Ind Health       Date:  1958-01

3.  The diagnostic and therapeutic use of edathamil calcium disodium (EDTA, versene) in excessive inorganic lead absorption.

Authors:  W J LECKIE; S L TOMPSETT
Journal:  Q J Med       Date:  1958-01

4.  Current therapeutics. CXVII. Calcium disodium versenate (sodium calciumedetate).

Authors:  P L BIDSTRUP
Journal:  Practitioner       Date:  1957-09
  4 in total
  2 in total

1.  Treatment of lead poisoning. A comparison between the effects of sodium calciumedetate and penicillamine administered orally and intravenously.

Authors:  S Selander
Journal:  Br J Ind Med       Date:  1967-10

2.  Studies in lead poisoning. Oral therapy with penicillamine: relationship between lead in blood and other laboratory tests.

Authors:  S Selander; K Cramér; L Hallberg
Journal:  Br J Ind Med       Date:  1966-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.